OR WAIT null SECS
The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.
July 09, 2025
Article
The first half of 2025 recap for nephrology spotlights renal FDA action, ERA 2025 Congress coverage, and updates in xenotransplantation.
July 08, 2025
Positive topline results showed patients who received 2 scheduled rilparencel injections experienced significant eGFR slope decline improvement.
July 05, 2025
The Q2 recap for nephrology spotlights key FDA decisions and top coverage from the 62nd European Renal Association Congress.
July 02, 2025
A review of the 16 novel drugs approved by the US Food and Drug Administration during the first half of 2025, with links to coverage from MJH Life Sciences publications.
This FDA News Month in Review provides a round-up of regulatory decisions from June 2025.
The month in review spotlights renal regulatory news and clinical trial data as well as coverage of the 62nd European Renal Association Congress.
June 30, 2025
Discover groundbreaking FDA approvals in 2025 that redefine treatment standards, enhance patient care, and address critical public health needs.
An audio recap of the top 5 stories in healthcare news from the week of 06/16-06/22
The CRL cited deficiencies previously identified at a third-party manufacturing vendor unrelated to OLC, and the Company plans to request a Type A meeting.
June 27, 2025
We spotlight 7 impactful regulatory decisions scheduled to occur during the second half of 2025.